1
|
Spijkers-Shaw S, Devlin R, Shields NJ, Feng X, Peck T, Lenihan-Geels G, Davis C, Young SL, La Flamme AC, Zubkova OV. Synthesis and Detection of BODIPY-, Biotin-, and 19 F- Labeled Single-Entity Dendritic Heparan Sulfate Mimetics. Angew Chem Int Ed Engl 2024; 63:e202316791. [PMID: 38308859 DOI: 10.1002/anie.202316791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2023] [Revised: 02/01/2024] [Accepted: 02/02/2024] [Indexed: 02/05/2024]
Abstract
Heparin and heparan sulfate (HS) are naturally occurring mammalian glycosaminoglycans, and their synthetic and semi-synthetic mimetics have attracted significant interest as potential therapeutics. However, understanding the mechanism of action by which HS, heparin, and HS mimetics have a biological effect is difficult due to their highly charged nature, broad protein interactomes, and variable structures. To address this, a library of novel single-entity dendritic mimetics conjugated to BODIPY, Fluorine-19 (19 F), and biotin was synthesized for imaging and localization studies. The novel dendritic scaffold allowed for the conjugation of labeling moieties without reducing the number of sulfated capping groups, thereby better mimicking the multivalent nature of HS-protein interactions. The 19 F labeled mimetics were assessed in phantom studies and were detected at concentrations as low as 5 mM. Flow cytometric studies using a fluorescently labeled mimetic showed that the compound associated with immune cells from tumors more readily than splenic counterparts and was directed to endosomal-lysosomal compartments within immune cells and cancer cells. Furthermore, the fluorescently labeled mimetic entered the central nervous system and was detectable in brain-infiltrating immune cells 24 hours after treatment. Here, we report the enabling methodology for rapidly preparing various labeled HS mimetics and molecular probes with diverse potential therapeutic applications.
Collapse
Affiliation(s)
- Sam Spijkers-Shaw
- The Ferrier Research Institute, Victoria University of Wellington, Gracefield Research Centre, Lower Hutt, New Zealand
- Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, 02115, United States
| | - Rory Devlin
- The Ferrier Research Institute, Victoria University of Wellington, Gracefield Research Centre, Lower Hutt, New Zealand
| | - Nicholas J Shields
- School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, Australia
| | - Xiang Feng
- MR Solutions Ltd., Guildford, Surrey, GU3 1LR, UK
- Sydney Imaging, Core Research Facility, The University of Sydney, NSW, 2006, Australia
| | - Tessa Peck
- School of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington, 6140, New Zealand
| | - Georgia Lenihan-Geels
- School of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington, 6140, New Zealand
| | - Connor Davis
- School of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington, 6140, New Zealand
| | - Sarah L Young
- School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, Australia
- Faculty of Science, University of Canterbury, Christchurch, New Zealand
| | - Anne C La Flamme
- School of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington, 6140, New Zealand
- Centre for Biodiscovery, Victoria University of Wellington, Kelburn Parade, Wellington, New Zealand
| | - Olga V Zubkova
- The Ferrier Research Institute, Victoria University of Wellington, Gracefield Research Centre, Lower Hutt, New Zealand
- Centre for Biodiscovery, Victoria University of Wellington, Kelburn Parade, Wellington, New Zealand
| |
Collapse
|
2
|
Access to n-pentenyl tetra- and pentasaccharide analogues of the antitumor drug PI-88 based on 1,2-methyl orthoester glycosyl donors. Carbohydr Res 2022; 516:108557. [DOI: 10.1016/j.carres.2022.108557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2022] [Revised: 04/07/2022] [Accepted: 04/07/2022] [Indexed: 11/19/2022]
|
3
|
Gomez AM, Lopez JC. Bringing Color to Sugars: The Chemical Assembly of Carbohydrates to BODIPY Dyes. CHEM REC 2021; 21:3112-3130. [PMID: 34472184 DOI: 10.1002/tcr.202100190] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Revised: 08/10/2021] [Indexed: 12/29/2022]
Abstract
The combination of carbohydrates with BODIPY fluorophores gives rise to a family of BODIPY-carbohydrate hybrids or glyco-BODIPYs, which mutually benefit from the encounter. Thus, from the carbohydrates standpoint, glyco-BODIPYs can be regarded as fluorescent glycoconjugate derivatives with application in imaging techniques, whereas from the fluorophore view the BODIPY-carbohydrate hybrids benefit from the biocompatibility, water-solubility, and reduced toxicity, among others, brought about by the sugar moiety. In this Account we have intended to present the collection of available methods for the synthesis of BODIPY-carbohydrate hybrids, with a focus on the chemical transformations on the BODIPY core.
Collapse
Affiliation(s)
- Ana M Gomez
- Bioorganic Chemistry Department, Instituto Quimica Organica General (IQOG-CSIC), Juan de la Cierva 3, 28006, Madrid, Spain
| | - J Cristobal Lopez
- Bioorganic Chemistry Department, Instituto Quimica Organica General (IQOG-CSIC), Juan de la Cierva 3, 28006, Madrid, Spain
| |
Collapse
|